This topic contains a solution. Click here to go to the answer

Author Question: When employing reversal designs in intrasubject research, two problems often occur: 1) the effect of ... (Read 21 times)

NguyenJ

  • Hero Member
  • *****
  • Posts: 516
When employing reversal designs in intrasubject research, two problems often occur: 1) the effect of the researcher's intervention may not be reversible; and 2)
 
  a. these designs require many between-subject manipulations
  b. implementing these AB designs is often expensive.
  c. it may be unethical to withdraw a beneficial treatment.
  d. it is difficult to recruit large numbers of subjects required in these designs.

Question 2

Compared to studies published in the Journal of Applied Psychology, articles that appear in the Journal of Experimental Psychology: Applied are likely to be
 
  a. laboratory-based.
  b. theoretical.
  c. correlational.
  d. longitudinal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ebonylittles

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

c

Answer to Question 2

A




NguyenJ

  • Member
  • Posts: 516
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


tuate

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library